Key Insights

Highlights

Success Rate

84% trial completion

Research Maturity

63 completed trials (44% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

8.3%

12 terminated out of 144 trials

Success Rate

84.0%

-2.5% vs benchmark

Late-Stage Pipeline

25%

36 trials in Phase 3/4

Results Transparency

16%

10 of 63 completed with results

Key Signals

10 with results84% success12 terminated

Data Visualizations

Phase Distribution

99Total
Not Applicable (47)
Early P 1 (2)
P 1 (4)
P 2 (10)
P 3 (17)
P 4 (19)

Trial Status

Completed63
Unknown31
Recruiting23
Terminated12
Withdrawn6
Not Yet Recruiting6

Trial Success Rate

84.0%

Benchmark: 86.5%

Based on 63 completed trials

Clinical Trials (144)

Showing 20 of 20 trials
NCT06966310Not ApplicableRecruitingPrimary

Awake Prone Positioning of Patients Suffering Community Acquired Pneumonia Requiring Nasal High Flow Therapy

NCT06996834Not ApplicableRecruitingPrimary

Noninvasive Support Methods for Acute Respiratory Failure of Community-acquired Pneumonia

NCT05848713Phase 3RecruitingPrimary

AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia

NCT06229288Phase 3RecruitingPrimary

Amoxicillin Alone Versus Amoxicillin/Clavulanate for Community-acquired Pneumonia in Patients Aged 65 Years or Older, and Hospitalized in a Non-intensive Care Unit Ward

NCT05962606Phase 2CompletedPrimary

Safety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia.

NCT05568654Not ApplicableActive Not RecruitingPrimary

Reducing Antimicrobial Overuse Through Targeted Therapy for Patients With Community-Acquired Pneumonia

NCT07442656RecruitingPrimary

Frailty and Outcomes in Older Emergency Department Patients With Pneumonia

NCT06272994Not ApplicableCompletedPrimary

Swab Testing to Optimize Pneumonia Treatment With Empiric Vancomycin

NCT05722938Phase 3RecruitingPrimary

Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)

NCT07357935Phase 1Not Yet Recruiting

Early Inflammatory-Immune Stratification and Precision Glucocorticoid Intervention in Acute Respiratory Failure Induced by Community-Acquired Pneumonia

NCT05826873Not ApplicableActive Not Recruiting

Discharge Stewardship in Children's Hospitals

NCT06202521Phase 2TerminatedPrimary

CX-4945 in Viral Community Acquired Pneumonia

NCT06294600Phase 3RecruitingPrimary

Clarithromycin Treatment to Prevent Sepsis Progression in CAP (REACT)

NCT07278700Recruiting

The Fever Clinic Acute Respiratory Cohort

NCT07279675Not Yet RecruitingPrimary

Clinical Predictors of Severity in Pediatric Community-Acquired Pneumonia at Assiut University Children's Hospital

NCT04210102Not ApplicableActive Not RecruitingPrimary

Community-Acquired Pneumonia Diagnosis Using Lung Ultrasound in Emergency Room Adults

NCT04350502Not ApplicableCompleted

Pharmacokinetics and Pleural Fluid Penetration of Amoxicillin and Clavulanic Acid in Patients With Pleural Infections

NCT06689280Not ApplicableNot Yet RecruitingPrimary

Physical Rehabilitation of Older Persons Following a Community-Acquired Infection Hospitalization - A Randomised-Controlled Trial

NCT01574066Not ApplicableCompletedPrimary

Chest CT-scan for the Diagnosis of Community-acquired Pneumonia

NCT03379207TerminatedPrimary

Innate Immune Response During Community Acquired Pneumonia

Scroll to load more

Research Network

Activity Timeline